From: SSH1 expression is associated with gastric cancer progression and predicts a poor prognosis
Clinico-pathologic features | Cancer | Adjacent to carcinoma |
---|---|---|
SSH1 (+) | 66 | 66 |
SSH1 (−) | 34 | 14 |
Age (years) | ||
≤ 55 | 21 | 17 |
>55 | 79 | 63 |
Gender | ||
Male | 64 | 47 |
Female | 36 | 33 |
Location | ||
Cardiac | 11 | 10 |
Fundus | 8 | 8 |
Corpora | 18 | 13 |
Sinuses | 57 | 46 |
Total | 6 | 3 |
Pathological type | ||
Glandular | 64 | 50 |
Signet ring cell | 12 | 9 |
Mucinous cell | 11 | 9 |
Undifferentiation | 12 | 11 |
Missing | 1 | 1 |
Lymph node metastasis | ||
Positive | 79 | 63 |
Negative | 21 | 17 |
Tumour infiltration | ||
T1 | 6 | 5 |
T2 | 7 | 4 |
T3 | 66 | 55 |
T4 | 20 | 15 |
Missing | 1 | 1 |
Size | ||
≥ 5 cm | 59 | 45 |
<5 cm | 39 | 35 |
Missing | 2 | 0 |
AJCC staging | ||
Stage I | 10 | 7 |
Stage II | 33 | 29 |
Stage III | 49 | 36 |
Stage IV | 7 | 7 |
Missing | 1 | 1 |